Literature DB >> 4856037

Animal model: feline GM1 gangliosidosis.

H J Baker, J R Lindsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4856037      PMCID： PMC1910786     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  5 in total

1.  Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man.

Authors:  D F Farrell; H J Baker; R M Herndon; J R Lindsey; G M McKhann
Journal:  J Neuropathol Exp Neurol       Date:  1973-01       Impact factor: 3.685

2.  Ganglioside storage diseases.

Authors:  J S O'Brien; S Okada; M W Ho; D L Fillerup; M L Veath; K Adams
Journal:  Fed Proc       Date:  1971 May-Jun

3.  GM-1 gangliosidosis in a cat.

Authors:  W F Blakemore
Journal:  J Comp Pathol       Date:  1972-04       Impact factor: 1.311

4.  Biochemical studies in cat and human gangliosidosis.

Authors:  S Handa; T Yamakawa
Journal:  J Neurochem       Date:  1971-07       Impact factor: 5.372

5.  Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency.

Authors:  H J Baker; J R Lindsey; G M McKhann; D F Farrell
Journal:  Science       Date:  1971-11-19       Impact factor: 47.728
  5 in total
  9 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Ultrastructural study on nervous system of fetus with GM1-gangliosidosis type 1.

Authors:  T Yamano; M Shimada; S Okada; T Yutaka; T Kato; K Inui; H Yabuuchi; S Kanzaki; S Kanda
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Sustained normalization of neurological disease after intracranial gene therapy in a feline model.

Authors:  Victoria J McCurdy; Aime K Johnson; Heather L Gray-Edwards; Ashley N Randle; Brandon L Brunson; Nancy E Morrison; Nouha Salibi; Jacob A Johnson; Misako Hwang; Ronald J Beyers; Stanley G Leroy; Stacy Maitland; Thomas S Denney; Nancy R Cox; Henry J Baker; Miguel Sena-Esteves; Douglas R Martin
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

4.  Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.

Authors:  Zeynep Akgoc; Miguel Sena-Esteves; Douglas R Martin; Xianlin Han; Alessandra d'Azzo; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2015-03-20       Impact factor: 5.922

5.  Generalized gangliosidosis type II (juvenile GM1 gangliosidosis). A pathological, histochemical and ultrastructural study.

Authors:  E F Gilbert; J Varakis; J M Opitz; G M ZuRhein; R Ware; C Viseskul; E G Kaveggia; H A Hartmann
Journal:  Z Kinderheilkd       Date:  1975-09-11

Review 6.  A review of gene therapy in canine and feline models of lysosomal storage disorders.

Authors:  Allison M Bradbury; Brittney L Gurda; Margret L Casal; Katherine P Ponder; Charles H Vite; Mark E Haskins
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-11       Impact factor: 5.032

7.  An electrophoretic variant of beta-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis.

Authors:  A G Norden; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

8.  Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosis.

Authors:  Karie A Heinecke; Adrienne Luoma; Alessandra d'Azzo; Daniel A Kirschner; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2015-02-18       Impact factor: 4.146

9.  Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis.

Authors:  Deborah Eikelberg; Annika Lehmbecker; Graham Brogden; Witchaya Tongtako; Kerstin Hahn; Andre Habierski; Julia B Hennermann; Hassan Y Naim; Felix Felmy; Wolfgang Baumgärtner; Ingo Gerhauser
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.